Event R&D Governance, Controlling and Innovation for Pharma 21/09/2026 - 07:00 - 23/09/2026 - 19:00 Frankfurt‚ Germany
Event The MFN effect: what payers expect and how Pharma should respond 22/09/2026 - 14:00 - 22/09/2026 - 15:00
Event 30th Portfolio Decision-Making & Prioritisation for Pharma 24/09/2026 - 08:00 - 25/09/2026 - 19:00 Frankfurt, Germany
Event 17th World ADC San Diego | October 12-15, 2026 12/10/2026 - 08:00 - 15/10/2026 - 18:00 San Diego
Event Register Now for AAPS PharmSci 360! 25/10/2026 - 08:00 - 28/10/2026 - 18:00 New Orleans, Louisiana
Event 2nd World-RNA Based Therapeutics & Vaccines Summit South Korea 10/11/2026 - 08:00 - 12/11/2026 - 19:00 Incheon, South Korea
Event World Novel Drug Discovery Summit South Korea 08/12/2026 - 08:00 - 10/12/2026 - 19:00 Incheon, South Korea
Event 2nd World-RNA Based Therapeutics & Vaccines Summit South Korea 10/11/2026 - 08:00 - 12/11/2026 - 19:00 Incheon, South Korea
News Novartis sets sights on new oral MS drug after phase 3 wins Novartis' oral BTK inhibitor remibrutinib has shown efficacy in a pair of phase 3 trials in multiple sclerosis, boosting its blockbuster credentials.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
